Pathogenetic rationale for the application of cytostatics for the complex treatment of acantholytic pemphigus

Please use this identifier to cite or link to this item: http://elar.urfu.ru/handle/10995/132500

Title:	Pathogenetic rationale for the application of cytostatics for the complex treatment of acantholytic pemphigus
Authors:	Kuklin, I. A. Kungurov, N. V. Kokhan, M. M. Kuklina, M. K.
Issue Date:	2014
Publisher:	Georg Thieme Verlag
Citation:	Kuklin, I. et al. (2014) ‘Pathogenetische Begründung der Anwendung von Zytostatika zur komplexen Therapie des Akantholytischen Pemphigus’, Aktuelle Dermatologie. Georg Thieme Verlag KG, 40(04), pp. 139–143. doi: 10.1055/s-0034-1364868. Kuklin, I., Kungurov, N., Kokhan, M., & Kuklina, M. (2014). Pathogenetische Begründung der Anwendung von Zytostatika zur komplexen Therapie des Akantholytischen Pemphigus. Aktuelle Dermatologie, 40(04), 139–143. doi:10.1055/s-0034-1364868
Abstract:	Following a brief review on the etiology, pathogenesis, clinical and pathomorphological criteria of diagnostics and principles of treatment of Acantholytic Pemphigus, clinical cases of Pemphigus vulgaris and their complex treatment using subcutaneous injections of methotrexate are described. © Georg Thieme Verlag KG Stuttgart New York ISSN 0340-2541.
Keywords:	CYTOSTATIC AGENT METHOTREXATE ACANTHOLYTIC PEMPHIGUS HUMAN PEMPHIGUS PEMPHIGUS VULGARIS PRACTICE GUIDELINE REVIEW
URI:	http://elar.urfu.ru/handle/10995/132500
Access:	info:eu-repo/semantics/openAccess
SCOPUS ID:	84898912340
PURE ID:	9805554
ISSN:	0340-2541
DOI:	10.1055/s-0034-1364868
Appears in Collections:	Научные публикации ученых УрФУ, проиндексированные в SCOPUS и WoS CC

Files in This Item:

File	Description	Size	Format
2-s2.0-84898912340.pdf		450,83 kB	Adobe PDF	View/Open